Non-Invasive Assessment of Isocitrate Dehydrogenase-Mutant Gliomas Using Optimized Proton Magnetic Resonance Spectroscopy on a Routine Clinical 3-Tesla MRI

SIMPLE SUMMARY: IDH mutation is one of the most important prognostic biomarkers in glioma management. Noninvasive neuroimaging techniques to predict IDH mutant glioma may be valuable for guiding clinical decision-making and monitoring response to targeted therapies. The aim of our prospective study...

Descripción completa

Detalles Bibliográficos
Autores principales: de Godoy, Laiz Laura, Lim, Kheng Choon, Rajan, Archith, Verma, Gaurav, Hanaoka, Mauro, O’Rourke, Donald M., Lee, John Y. K., Desai, Arati, Chawla, Sanjeev, Mohan, Suyash
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10526791/
https://www.ncbi.nlm.nih.gov/pubmed/37760422
http://dx.doi.org/10.3390/cancers15184453

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10526791/
https://www.ncbi.nlm.nih.gov/pubmed/37760422
http://dx.doi.org/10.3390/cancers15184453

Ejemplares similares